Last 3.46 INR
Change Today 0.00 / 0.00%
Volume 0.0
SBIL On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for saamya biotech india ltd (SBIL)

Year over year, Saamya Biotech (India) Limited has been able to grow revenues from 29.8M INR to 133.6M INR. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 13.43% to 0.66%. This was a driver that led to a bottom line growth from a loss of 4.0M INR to a gain of 953.3K INR.
View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Mar 31
2011
Restated
INR
Mar 31
2012
INR
Mar 31
2013
INR
Mar 31
2014
Press
Release

INR
4 Year
Trend
Revenues162.8230.729.8133.6
Other Revenues--0.0----
TOTAL REVENUES162.8230.729.8133.6
Cost of Goods Sold154.8213.328.1127.3
GROSS PROFIT8.017.31.76.4
Selling General & Admin Expenses, Total3.411.04.00.9
Depreciation & Amortization, Total0.70.70.71.2
Other Operating Expenses0.40.40.42.6
OTHER OPERATING EXPENSES, TOTAL4.412.15.14.7
OPERATING INCOME3.65.2-3.41.7
Interest Expense-0.2-7.9-0.2-0.2
NET INTEREST EXPENSE-0.2-7.9-0.2-0.2
Currency Exchange Gains (Loss)--6.6----
Other Non-Operating Income (Expenses)-0.2-0.2-0.1--
EBT, EXCLUDING UNUSUAL ITEMS3.23.6-3.71.5
Gain (Loss) on Sale of Investments0.0------
Gain (Loss) on Sale of Assets-1.2-0.1-0.4--
EBT, INCLUDING UNUSUAL ITEMS1.93.5-4.11.5
Income Tax Expense1.00.8-0.10.6
Earnings from Continuing Operations0.92.8-4.01.0
NET INCOME0.92.8-4.01.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS0.92.8-4.01.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS0.92.8-4.01.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SBIL:IN 3.46 INR 0.00

SBIL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SBIL.
View Industry Companies
 

Industry Analysis

SBIL

Industry Average

Valuation SBIL Industry Range
Price/Earnings 89.3x
Price/Sales 0.7x
Price/Book 0.3x
Price/Cash Flow 41.6x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAAMYA BIOTECH INDIA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.